Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313
Asrar Qureshi’s blog delves into the complex journey of health innovations from discovery to patient access, highlighting the significant costs and time involved in drug development. It emphasizes the need for a collaborative approach between pharmaceutical companies and governments to address pricing, making life-saving medications accessible while managing risks and uncertainties effectively.
